Retatrutide (LY-3437943) is a novel peptide compound developed for research purposes in the field of metabolic disorders and weight management. This GLP-1 receptor agonist peptide features a unique molecular structure with modifications that enhance its stability and biological activity.
The peptide contains two significant structural modifications: replacement of Gly with 2-aminoisobutyric acid (Aib) at position 2, and attachment of octadecanoic diacid to the side chain of Lys-26 through a polyethylene glycol (PEG) spacer. These modifications contribute to increased resistance to DPP-4 degradation and improved binding affinity.
Retatrutide is supplied as a lyophilized powder in sterile vials with 99% purity, making it suitable for various research applications. The product is carefully packaged to ensure stability and maintain its research-grade quality.
For laboratory research use only. This product is not intended for human consumption or diagnostic use.
Promptly delivered by the courier service, which was a pleasant surprise. The packaging was secure and intact, ensuring the product arrived in perfect condition. Pristine quality is evident from the sealed vials and clear labeling, reflecting high standards. Professional service from the team, with quick responses to my inquiries and smooth transaction process. Overall, a reliable experience that met my expectations without any issues.